72例惊恐障碍患者的医疗费用调查  

Investigation on medical cost of 72 patients with panic disorder

作　　者：陈伟星[1] 李亮[1] 赵勤练[1] 谭江[1] 

机构地区：[1]江门市新会区人民医院神经内科,广东省江门529100

出　　处：《中国基层医药》2007年第12期1964-1965,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的调查惊恐障碍患者的医疗费用及选择性5羟色胺再摄取抑制剂(SSRIs)帕罗西汀对惊恐障碍的疗效。方法调查72例患者的医疗费用、病程、就诊次数、所做的主要辅助检查的种类及次数。同时用焦虑、抑郁量表观察了帕罗西汀对惊恐障碍的疗效。结果惊恐障碍患者有较长的病程,病程中接受了很多不必要的辅助检查同时花费了大量的医疗费用。帕罗西汀能明显降低惊恐障碍患者的焦虑、抑郁的评分。结论惊恐障碍患者在确诊前有较长的病程,花费了大量的医疗费用。帕罗西汀是一种治疗惊恐障碍的安全、有效的药物。Objective To investigate the medical cost of 72 patients with panic disorder and efficacy of paroxetine（SSRIs） in the treatment. Methods The course,medical cost, types and times of main examination of all 72 patients were reviewed and analyzed. The effect of paroxetine on the patients was studied in terms of anxiety and depression scale. Results The 72 patients had long course, high medical cost and received many unnecessary medical examinations. Paroxetine was effective on patients with panic disorder in light of anxiety and depression scale.Conclusion Patients with panic disorder had long course and spent much unnecessany money before final diagnosis. Paroxetine was useful and safe in the treatment of panic disorder.

关 键 词：惊恐障碍 医疗费用 帕罗西汀 

分 类 号：R749.7[医药卫生—神经病学与精神病学]